Patent · US Active

Composition for the treatment of intracellular bacterial infection

US11648287B2 · kind B2 · utility

0Cited by
2References
23Claims
0Family size

Assignees

Inventors

Key dates

Filing dateNov 9, 2018
Grant dateMay 16, 2023
Priority date
Expiry dateNov 9, 2038

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method of treating or preventing an intracellular bacterial infection, comprising contacting the cell(s) which are infected with an antibacterial agent and a photosensitizing agent and irradiating the cell(s) with light of a wavelength effective to activate the photosensitizing agent, wherein the antibacterial agent is released into the cytosol of the cell(s) and kills, damages or prevents the replication of bacteria in said cell(s) is described. Related uses, and compositions, products and kits for the same are further described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.